杉本 直志

Last Update: 2021/06/24 12:17:55

Print

Name(Kanji/Kana/Abecedarium Latinum)
杉本 直志/スギモト ナオシ/Sugimoto, Naoshi
Primary Affiliation(Org1/Job title)
Center for iPS Cell Research and Application (CiRA)/Program-Specific Research Center Senior Lecturer/Program-Specific Research Center Junior Associate Professor
Academic Organizations You are Affiliated to in Japan
Organization name(Japanese) Organization name(English)
日本内科学会
日本血液学会
Academic Degree
Field(Japanese) Field(English) University(Japanese) University(English) Method
博士(医学) 京都大学
ORCID ID
https://orcid.org/0000-0002-7271-9175
researchmap URL
https://researchmap.jp/7000015500
Published Papers
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
Akinori Yuzuriha, Sou Nakamura, Naoshi Sugimoto, Shunsuke Kihara, Masato Nakagawa, Takuya Yamamoto, Kiyotoshi Sekiguchi, Koji Eto Akinori Yuzuriha, Sou Nakamura, Naoshi Sugimoto, Shunsuke Kihara, Masato Nakagawa, Takuya Yamamoto, Kiyotoshi Sekiguchi, Koji Eto Akinori Yuzuriha, Sou Nakamura, Naoshi Sugimoto, Shunsuke Kihara, Masato Nakagawa, Takuya Yamamoto, Kiyotoshi Sekiguchi, Koji Eto Extracellular laminin regulates hematopoietic potential of pluripotent stem cells through integrin β1-ILK-β-catenin-JUN axis. Extracellular laminin regulates hematopoietic potential of pluripotent stem cells through integrin β1-ILK-β-catenin-JUN axis. Extracellular laminin regulates hematopoietic potential of pluripotent stem cells through integrin β1-ILK-β-catenin-JUN axis. Stem cell research, 53, 102287-102287 Stem cell research, 53, 102287-102287 Stem cell research, 53, 102287-102287 2021/05 English Research paper(scientific journal) Disclose to all
Naoshi Sugimoto, Koji Eto Naoshi Sugimoto, Koji Eto Naoshi Sugimoto, Koji Eto Generation and manipulation of human iPSC-derived platelets. Generation and manipulation of human iPSC-derived platelets. Generation and manipulation of human iPSC-derived platelets. Cellular and molecular life sciences : CMLS, 78, 7, 3385-3401 Cellular and molecular life sciences : CMLS, 78, 7, 3385-3401 Cellular and molecular life sciences : CMLS, 78, 7, 3385-3401 2021/04 English Research paper(scientific journal) Disclose to all
Yoshitsugu Sugiura, Naoshi Sugimoto, Takayuki Takahashi, Tadahiko Matsumoto Yoshitsugu Sugiura, Naoshi Sugimoto, Takayuki Takahashi, Tadahiko Matsumoto Yoshitsugu Sugiura, Naoshi Sugimoto, Takayuki Takahashi, Tadahiko Matsumoto Dual fungal infection with Lomentospora prolificans and Aspergillus fumigatus: A pathogenetic diagnosis elucidated after two decades by sequential examinations. Dual fungal infection with Lomentospora prolificans and Aspergillus fumigatus: A pathogenetic diagnosis elucidated after two decades by sequential examinations. Dual fungal infection with Lomentospora prolificans and Aspergillus fumigatus: A pathogenetic diagnosis elucidated after two decades by sequential examinations. Clinical case reports, 9, 3, 1383-1386 Clinical case reports, 9, 3, 1383-1386 Clinical case reports, 9, 3, 1383-1386 2021/03 English Disclose to all
Ryo Ishino, Yumi Kawase, Toshio Kitawaki, Naoshi Sugimoto, Maki Oku, Shumpei Uchida, Osamu Imataki, Akihito Matsuoka, Teruhisa Taoka, Kimihiro Kawakami, Toin H van Kuppevelt, Tomoki Todo, Akifumi Takaori-Kondo, Norimitsu Kadowaki Ryo Ishino, Yumi Kawase, Toshio Kitawaki, Naoshi Sugimoto, Maki Oku, Shumpei Uchida, Osamu Imataki, Akihito Matsuoka, Teruhisa Taoka, Kimihiro Kawakami, Toin H van Kuppevelt, Tomoki Todo, Akifumi Takaori-Kondo, Norimitsu Kadowaki Ryo Ishino, Yumi Kawase, Toshio Kitawaki, Naoshi Sugimoto, Maki Oku, Shumpei Uchida, Osamu Imataki, Akihito Matsuoka, Teruhisa Taoka, Kimihiro Kawakami, Toin H van Kuppevelt, Tomoki Todo, Akifumi Takaori-Kondo, Norimitsu Kadowaki Oncolytic Virus Therapy with HSV-1 for Hematological Malignancies. Oncolytic Virus Therapy with HSV-1 for Hematological Malignancies. Oncolytic Virus Therapy with HSV-1 for Hematological Malignancies. Molecular therapy : the journal of the American Society of Gene Therapy, 29, 2, 762-774 Molecular therapy : the journal of the American Society of Gene Therapy, 29, 2, 762-774 Molecular therapy : the journal of the American Society of Gene Therapy, 29, 2, 762-774 2021/02/03 English Research paper(scientific journal) Disclose to all
Sou Nakamura, Naoshi Sugimoto, Koji Eto Sou Nakamura, Naoshi Sugimoto, Koji Eto Sou Nakamura, Naoshi Sugimoto, Koji Eto Development of platelet replacement therapy using human induced pluripotent stem cells. Development of platelet replacement therapy using human induced pluripotent stem cells. Development of platelet replacement therapy using human induced pluripotent stem cells. Development, growth & differentiation, 63, 2, 178-186 Development, growth & differentiation, 63, 2, 178-186 Development, growth & differentiation, 63, 2, 178-186 2021/02 English Research paper(scientific journal) Disclose to all
Maki Oku, Ryo Ishino, Shumpei Uchida, Osamu Imataki, Naoshi Sugimoto, Tomoki Todo, Norimitsu Kadowaki Maki Oku, Ryo Ishino, Shumpei Uchida, Osamu Imataki, Naoshi Sugimoto, Tomoki Todo, Norimitsu Kadowaki Maki Oku, Ryo Ishino, Shumpei Uchida, Osamu Imataki, Naoshi Sugimoto, Tomoki Todo, Norimitsu Kadowaki Oncolytic herpes simplex virus type 1 (HSV-1) in combination with lenalidomide for plasma cell neoplasms. Oncolytic herpes simplex virus type 1 (HSV-1) in combination with lenalidomide for plasma cell neoplasms. Oncolytic herpes simplex virus type 1 (HSV-1) in combination with lenalidomide for plasma cell neoplasms. British journal of haematology, 192, 2, 343-353 British journal of haematology, 192, 2, 343-353 British journal of haematology, 192, 2, 343-353 2021/01 English Research paper(scientific journal) Disclose to all
Charlotte Flahou, Tatsuya Morishima, Hitoshi Takizawa, Naoshi Sugimoto Charlotte Flahou, Tatsuya Morishima, Hitoshi Takizawa, Naoshi Sugimoto Charlotte Flahou, Tatsuya Morishima, Hitoshi Takizawa, Naoshi Sugimoto Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity. Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity. Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice With NK Cell Immunity. Frontiers in immunology, 12, 662360-662360 Frontiers in immunology, 12, 662360-662360 Frontiers in immunology, 12, 662360-662360 2021 English Research paper(scientific journal) Disclose to all
Sou Nakamura, Naoshi Sugimoto, Koji Eto Sou Nakamura, Naoshi Sugimoto, Koji Eto Sou Nakamura, Naoshi Sugimoto, Koji Eto Ex vivo generation of platelet products from human iPS cells. Ex vivo generation of platelet products from human iPS cells. Ex vivo generation of platelet products from human iPS cells. Inflammation and regeneration, 40, 1, 30-30 Inflammation and regeneration, 40, 1, 30-30 Inflammation and regeneration, 40, 1, 30-30 2020/12/01 English Research paper(scientific journal) Disclose to all
Daisuke Suzuki, Charlotte Flahou, Norihide Yoshikawa, Ieva Stirblyte, Yoshikazu Hayashi, Akira Sawaguchi, Marina Akasaka, Sou Nakamura, Natsumi Higashi, Huaigeng Xu, Takuya Matsumoto, Kosuke Fujio, Markus G Manz, Akitsu Hotta, Hitoshi Takizawa, Koji Eto, Naoshi Sugimoto Daisuke Suzuki, Charlotte Flahou, Norihide Yoshikawa, Ieva Stirblyte, Yoshikazu Hayashi, Akira Sawaguchi, Marina Akasaka, Sou Nakamura, Natsumi Higashi, Huaigeng Xu, Takuya Matsumoto, Kosuke Fujio, Markus G Manz, Akitsu Hotta, Hitoshi Takizawa, Koji Eto, Naoshi Sugimoto Daisuke Suzuki, Charlotte Flahou, Norihide Yoshikawa, Ieva Stirblyte, Yoshikazu Hayashi, Akira Sawaguchi, Marina Akasaka, Sou Nakamura, Natsumi Higashi, Huaigeng Xu, Takuya Matsumoto, Kosuke Fujio, Markus G Manz, Akitsu Hotta, Hitoshi Takizawa, Koji Eto, Naoshi Sugimoto iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity. Stem cell reports, 14, 1, 49-59 Stem cell reports, 14, 1, 49-59 Stem cell reports, 14, 1, 49-59 2020/01/14 Refereed English Research paper(scientific journal) Disclose to all
Kazuyo Yamamoto, Toshio Kitawaki, Naoshi Sugimoto, Haruyuki Fujita, Yumi Kawase, Akifumi Takaori-Kondo, Norimitsu Kadowaki Kazuyo Yamamoto, Toshio Kitawaki, Naoshi Sugimoto, Haruyuki Fujita, Yumi Kawase, Akifumi Takaori-Kondo, Norimitsu Kadowaki Kazuyo Yamamoto, Toshio Kitawaki, Naoshi Sugimoto, Haruyuki Fujita, Yumi Kawase, Akifumi Takaori-Kondo, Norimitsu Kadowaki Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide. Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide. Anti-inflammatory modulation of human myeloid-derived dendritic cell subsets by lenalidomide. Immunology letters, 211, 41-48 Immunology letters, 211, 41-48 Immunology letters, 211, 41-48 2019/07 Refereed English Research paper(scientific journal) Disclose to all
Naoshi Sugimoto, Koji Eto Naoshi Sugimoto, Koji Eto Naoshi Sugimoto, Koji Eto αIIbβ3 changes gears in MKs and platelets. αIIbβ3 changes gears in MKs and platelets. αIIbβ3 changes gears in MKs and platelets. Blood, 133, 16, 1700-1701 Blood, 133, 16, 1700-1701 Blood, 133, 16, 1700-1701 2019/04/18 Refereed English Research paper(scientific journal) Disclose to all
杉本直志, 江藤浩之, 江藤浩之 杉本直志, 江藤浩之, 江藤浩之 杉本直志, 江藤浩之, 江藤浩之 Reconstitution of the hematopoietic system and clinical applications of iPS cells iPS細胞技術を用いた造血システムの再構成と治療への応用 Reconstitution of the hematopoietic system and clinical applications of iPS cells 臨床血液, 60, 9, 1046-1055 臨床血液, 60, 9, 1046-1055 臨床血液, 60, 9, 1046-1055 2019 Refereed Japanese Disclose to all
Hideya Seo, Si Jing Chen, Kazuya Hashimoto, Hiroshi Endo, Yohei Nishi, Akira Ohta, Takuya Yamamoto, Akitsu Hotta, Akira Sawaguchi, Hideki Hayashi, Noritaka Koseki, George J Murphy, Kazuhiko Fukuda, Naoshi Sugimoto, Koji Eto Seo H, Chen SJ, Hashimoto K, Endo H, Nishi Y, Ohta A, Yamamoto T, Hotta A, Sawaguchi A, Hayashi H, Koseki N, Murphy GJ, Fukuda K, Sugimoto N, Eto K Hideya Seo, Si Jing Chen, Kazuya Hashimoto, Hiroshi Endo, Yohei Nishi, Akira Ohta, Takuya Yamamoto, Akitsu Hotta, Akira Sawaguchi, Hideki Hayashi, Noritaka Koseki, George J Murphy, Kazuhiko Fukuda, Naoshi Sugimoto, Koji Eto A β1-tubulin-based megakaryocyte maturation reporter system identifies novel drugs that promote platelet production. A β1-tubulin-based megakaryocyte maturation reporter system identifies novel drugs that promote platelet production. A β1-tubulin-based megakaryocyte maturation reporter system identifies novel drugs that promote platelet production. Blood advances, 2, 17, 2262-2272 Blood Advances, 2, 17, 2262-2272 Blood advances, 2, 17, 2262-2272 2018/09/11 Refereed English Research paper(scientific journal) Disclose to all
杉本 直志, 鈴木 大助, シャオミン・フェング, 吉川 典秀, 赤坂 まりな, 中村 壮, 遠藤 大, 堀田 秋津, 滝澤 仁, 江藤 浩之 杉本 直志, 鈴木 大助, シャオミン・フェング, 吉川 典秀, 赤坂 まりな, 中村 壮, 遠藤 大, 堀田 秋津, 滝澤 仁, 江藤 浩之 杉本 直志, 鈴木 大助, シャオミン・フェング, 吉川 典秀, 赤坂 まりな, 中村 壮, 遠藤 大, 堀田 秋津, 滝澤 仁, 江藤 浩之 HLAクラスI欠失ヒトiPS細胞由来血小板の抗HLA抗体およびNK細胞に対する免疫逃避(HLA class-I depleted human iPSC-derived platelets evade anti-HLA and NK cell immunity) HLAクラスI欠失ヒトiPS細胞由来血小板の抗HLA抗体およびNK細胞に対する免疫逃避(HLA class-I depleted human iPSC-derived platelets evade anti-HLA and NK cell immunity) HLAクラスI欠失ヒトiPS細胞由来血小板の抗HLA抗体およびNK細胞に対する免疫逃避(HLA class-I depleted human iPSC-derived platelets evade anti-HLA and NK cell immunity) 臨床血液, 59, 9, 1686-1686 臨床血液, 59, 9, 1686-1686 臨床血液, 59, 9, 1686-1686 2018/09 Refereed English Disclose to all
Yukitaka Ito, Sou Nakamura, Naoshi Sugimoto, Tomohiro Shigemori, Yoshikazu Kato, Mikiko Ohno, Shinya Sakuma, Keitaro Ito, Hiroki Kumon, Hidenori Hirose, Haruki Okamoto, Masayuki Nogawa, Mio Iwasaki, Shunsuke Kihara, Kosuke Fujio, Takuya Matsumoto, Natsumi Higashi, Kazuya Hashimoto, Akira Sawaguchi, Ken-Ichi Harimoto, Masato Nakagawa, Takuya Yamamoto, Makoto Handa, Naohide Watanabe, Eiichiro Nishi, Fumihito Arai, Satoshi Nishimura, Koji Eto Ito Y, Nakamura S, Sugimoto N, Shigemori T, Kato Y, Ohno M, Sakuma S, Ito K, Kumon H, Hirose H, Okamoto H, Nogawa M, Iwasaki M, Kihara S, Fujio K, Matsumoto T, Higashi N, Hashimoto K, Sawaguchi A, Harimoto KI, Nakagawa M, Yamamoto T, Handa M, Watanabe N, Nishi E, Arai F, Nishimura S, Eto K Yukitaka Ito, Sou Nakamura, Naoshi Sugimoto, Tomohiro Shigemori, Yoshikazu Kato, Mikiko Ohno, Shinya Sakuma, Keitaro Ito, Hiroki Kumon, Hidenori Hirose, Haruki Okamoto, Masayuki Nogawa, Mio Iwasaki, Shunsuke Kihara, Kosuke Fujio, Takuya Matsumoto, Natsumi Higashi, Kazuya Hashimoto, Akira Sawaguchi, Ken-Ichi Harimoto, Masato Nakagawa, Takuya Yamamoto, Makoto Handa, Naohide Watanabe, Eiichiro Nishi, Fumihito Arai, Satoshi Nishimura, Koji Eto Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production. Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production. Turbulence Activates Platelet Biogenesis to Enable Clinical Scale Ex Vivo Production. Cell, 174, 3, 636-648 Cell, 174, 3, 636-648 Cell, 174, 3, 636-648 2018/07/26 Refereed English Research paper(scientific journal) Disclose to all
杉本直志, 杉本直志, 江藤浩之, 江藤浩之 杉本直志, 杉本直志, 江藤浩之, 江藤浩之 杉本直志, 杉本直志, 江藤浩之, 江藤浩之 Ex vivo platelet production from induced pluripotent stem cells iPS細胞からの血小板産生 Ex vivo platelet production from induced pluripotent stem cells 臨床血液, 59, 10, 1905-1913 臨床血液, 59, 10, 1905-1913 臨床血液, 59, 10, 1905-1913 2018 Japanese Disclose to all
Shinji Hirata, Takahiko Murata, Daisuke Suzuki, Sou Nakamura, Ryoko Jono-Ohnishi, Hidenori Hirose, Akira Sawaguchi, Satoshi Nishimura, Naoshi Sugimoto, Koji Eto Hirata S, Murata T, Suzuki D, Nakamura S, Jono-Ohnishi R, Hirose H, Sawaguchi A, Nishimura S, Sugimoto N, Eto K Shinji Hirata, Takahiko Murata, Daisuke Suzuki, Sou Nakamura, Ryoko Jono-Ohnishi, Hidenori Hirose, Akira Sawaguchi, Satoshi Nishimura, Naoshi Sugimoto, Koji Eto Selective Inhibition of ADAM17 Efficiently Mediates Glycoprotein Ibα Retention During Ex Vivo Generation of Human Induced Pluripotent Stem Cell-Derived Platelets. Selective Inhibition of ADAM17 Efficiently Mediates Glycoprotein Ibα Retention During Ex Vivo Generation of Human Induced Pluripotent Stem Cell-Derived Platelets. Selective Inhibition of ADAM17 Efficiently Mediates Glycoprotein Ibα Retention During Ex Vivo Generation of Human Induced Pluripotent Stem Cell-Derived Platelets. Stem cells translational medicine, 6, 3, 720-730 Stem Cells Translational Medicine, 6, 3, 720-730 Stem cells translational medicine, 6, 3, 720-730 2017/03 Refereed English Research paper(scientific journal) Disclose to all
Ayako Aihara, Tomo Koike, Natsuki Abe, Sou Nakamura, Akira Sawaguchi, Takanori Nakamura, Naoshi Sugimoto, Hiromitsu Nakauchi, Taito Nishino, Koji Eto Ayako Aihara, Tomo Koike, Natsuki Abe, Sou Nakamura, Akira Sawaguchi, Takanori Nakamura, Naoshi Sugimoto, Hiromitsu Nakauchi, Taito Nishino, Koji Eto Ayako Aihara, Tomo Koike, Natsuki Abe, Sou Nakamura, Akira Sawaguchi, Takanori Nakamura, Naoshi Sugimoto, Hiromitsu Nakauchi, Taito Nishino, Koji Eto Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells. Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells. Novel TPO receptor agonist TA-316 contributes to platelet biogenesis from human iPS cells. Blood advances, 1, 7, 468-476 Blood advances, 1, 7, 468-476 Blood advances, 1, 7, 468-476 2017/02/28 Refereed English Research paper(scientific journal) Disclose to all
K-I Ishiyama, T. Kitawaki, N. Sugimoto, T. Sozu, N. Anzai, M. Okada, M. Nohgawa, K. Hatanaka, N. Arima, T. Ishikawa, S. Tabata, T. Onaka, S. Oka, Y. Nakabo, R. Amakawa, M. Matsui, T. Moriguchi, A. Takaori-Kondo, N. Kadowaki K-I Ishiyama, T. Kitawaki, N. Sugimoto, T. Sozu, N. Anzai, M. Okada, M. Nohgawa, K. Hatanaka, N. Arima, T. Ishikawa, S. Tabata, T. Onaka, S. Oka, Y. Nakabo, R. Amakawa, M. Matsui, T. Moriguchi, A. Takaori-Kondo, N. Kadowaki K-I Ishiyama, T. Kitawaki, N. Sugimoto, T. Sozu, N. Anzai, M. Okada, M. Nohgawa, K. Hatanaka, N. Arima, T. Ishikawa, S. Tabata, T. Onaka, S. Oka, Y. Nakabo, R. Amakawa, M. Matsui, T. Moriguchi, A. Takaori-Kondo, N. Kadowaki Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib LEUKEMIA, 31, 1, 203-212 LEUKEMIA, 31, 1, 203-212 LEUKEMIA, 31, 1, 203-212 2017/01 Refereed English Research paper(scientific journal) Disclose to all
Sugimoto N, Eto K Sugimoto N, Eto K Sugimoto N, Eto K Development of iPS cell-derived blood products and production guidelines. Development of iPS cell-derived blood products and production guidelines. Development of iPS cell-derived blood products and production guidelines. [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, 58, 10, 2150-2159 [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, 58, 10, 2150-2159 [Rinsho Ketsueki] The Japanese Journal of Clinical Hematology, 58, 10, 2150-2159 2017 Refereed Disclose to all
K. Ishiyama, J. Takeda, T. Kondo, N. Sugimoto, H. Kawabata, T. Kitano, A. Takaori-Kondo K. Ishiyama, J. Takeda, T. Kondo, N. Sugimoto, H. Kawabata, T. Kitano, A. Takaori-Kondo K. Ishiyama, J. Takeda, T. Kondo, N. Sugimoto, H. Kawabata, T. Kitano, A. Takaori-Kondo Feasibility of salvage cord blood transplantation following fludarabine, melphalan and low-dose TBI for graft rejection after hematopoietic stem cell transplantation Feasibility of salvage cord blood transplantation following fludarabine, melphalan and low-dose TBI for graft rejection after hematopoietic stem cell transplantation Feasibility of salvage cord blood transplantation following fludarabine, melphalan and low-dose TBI for graft rejection after hematopoietic stem cell transplantation BONE MARROW TRANSPLANTATION, 51, 7, 985-987 BONE MARROW TRANSPLANTATION, 51, 7, 985-987 BONE MARROW TRANSPLANTATION, 51, 7, 985-987 2016/07 Refereed English Disclose to all
Wenwen Sha, Hiroki Mitoma, Shino Hanabuchi, Musheng Bao, Leiyun Weng, Naoshi Sugimoto, Ying Liu, Zhiqiang Zhang, Jin Zhong, Bing Sun, Yong-Jun Liu Wenwen Sha, Hiroki Mitoma, Shino Hanabuchi, Musheng Bao, Leiyun Weng, Naoshi Sugimoto, Ying Liu, Zhiqiang Zhang, Jin Zhong, Bing Sun, Yong-Jun Liu Wenwen Sha, Hiroki Mitoma, Shino Hanabuchi, Musheng Bao, Leiyun Weng, Naoshi Sugimoto, Ying Liu, Zhiqiang Zhang, Jin Zhong, Bing Sun, Yong-Jun Liu Human NLRP3 inflammasome senses multiple types of bacterial RNAs. Human NLRP3 inflammasome senses multiple types of bacterial RNAs. Human NLRP3 inflammasome senses multiple types of bacterial RNAs. Proceedings of the National Academy of Sciences of the United States of America, 111, 45, 16059-64 Proceedings of the National Academy of Sciences of the United States of America, 111, 45, 16059-64 Proceedings of the National Academy of Sciences of the United States of America, 111, 45, 16059-64 2014/11/11 Refereed English Research paper(scientific journal) Disclose to all
Kui Shin Voo, Laura Bover, Megan Lundell Harline, Jinsheng Weng, Naoshi Sugimoto, Yong-Jun Liu Kui Shin Voo, Laura Bover, Megan Lundell Harline, Jinsheng Weng, Naoshi Sugimoto, Yong-Jun Liu Kui Shin Voo, Laura Bover, Megan Lundell Harline, Jinsheng Weng, Naoshi Sugimoto, Yong-Jun Liu Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells. Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells. Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells. Journal of immunology (Baltimore, Md. : 1950), 193, 2, 627-34 Journal of immunology (Baltimore, Md. : 1950), 193, 2, 627-34 Journal of immunology (Baltimore, Md. : 1950), 193, 2, 627-34 2014/07/15 Refereed English Research paper(scientific journal) Disclose to all
Naoshi Sugimoto, Hiroki Mitoma, Taeil Kim, Shino Hanabuchi, Yong-Jun Liu Naoshi Sugimoto, Hiroki Mitoma, Taeil Kim, Shino Hanabuchi, Yong-Jun Liu Naoshi Sugimoto, Hiroki Mitoma, Taeil Kim, Shino Hanabuchi, Yong-Jun Liu Helicase proteins DHX29 and RIG-I cosense cytosolic nucleic acids in the human airway system. Helicase proteins DHX29 and RIG-I cosense cytosolic nucleic acids in the human airway system. Helicase proteins DHX29 and RIG-I cosense cytosolic nucleic acids in the human airway system. Proceedings of the National Academy of Sciences of the United States of America, 111, 21, 7747-52 Proceedings of the National Academy of Sciences of the United States of America, 111, 21, 7747-52 Proceedings of the National Academy of Sciences of the United States of America, 111, 21, 7747-52 2014/05/27 Refereed English Research paper(scientific journal) Disclose to all
Hiroki Mitoma, Shino Hanabuchi, Taeil Kim, Musheng Bao, Zhiqiang Zhang, Naoshi Sugimoto, Yong-Jun Liu Hiroki Mitoma, Shino Hanabuchi, Taeil Kim, Musheng Bao, Zhiqiang Zhang, Naoshi Sugimoto, Yong-Jun Liu Hiroki Mitoma, Shino Hanabuchi, Taeil Kim, Musheng Bao, Zhiqiang Zhang, Naoshi Sugimoto, Yong-Jun Liu The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome. The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome. The DHX33 RNA helicase senses cytosolic RNA and activates the NLRP3 inflammasome. Immunity, 39, 1, 123-35 Immunity, 39, 1, 123-35 Immunity, 39, 1, 123-35 2013/07/25 Refereed English Research paper(scientific journal) Disclose to all
Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, Yamaguchi T, Nomura T, Ito H, Nakamura T, Sakaguchi N, Sakaguchi S Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, Yamaguchi T, Nomura T, Ito H, Nakamura T, Sakaguchi N, Sakaguchi S Hirota K, Yoshitomi H, Hashimoto M, Maeda S, Teradaira S, Sugimoto N, Yamaguchi T, Nomura T, Ito H, Nakamura T, Sakaguchi N, Sakaguchi S Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. J Exp Med. 2007 Nov 26;204(12):2803-12. J Exp Med. 2007 Nov 26;204(12):2803-12. J Exp Med. 2007 Nov 26;204(12):2803-12. 2013/07/16 Refereed English Disclose to all
Haiyan S Li, Nathaniel Greeley, Naoshi Sugimoto, Yong-Jun Liu, Stephanie S Watowich Haiyan S Li, Nathaniel Greeley, Naoshi Sugimoto, Yong-Jun Liu, Stephanie S Watowich Haiyan S Li, Nathaniel Greeley, Naoshi Sugimoto, Yong-Jun Liu, Stephanie S Watowich miR-22 controls Irf8 mRNA abundance and murine dendritic cell development. miR-22 controls Irf8 mRNA abundance and murine dendritic cell development. miR-22 controls Irf8 mRNA abundance and murine dendritic cell development. PloS one, 7, 12, e52341 PloS one, 7, 12, e52341 PloS one, 7, 12, e52341 2012 Refereed English Research paper(scientific journal) Disclose to all
Keiji Hirota, Hiroyuki Yoshitomi, Motomu Hashimoto, Shinji Maeda, Shin Teradaira, Naoshi Sugimoto, Tomoyuki Yamaguchi, Takashi Nomura, Hiromu Ito, Takashi Nakamura, Noriko Sakaguchi, Shimon Sakaguchi Keiji Hirota, Hiroyuki Yoshitomi, Motomu Hashimoto, Shinji Maeda, Shin Teradaira, Naoshi Sugimoto, Tomoyuki Yamaguchi, Takashi Nomura, Hiromu Ito, Takashi Nakamura, Noriko Sakaguchi, Shimon Sakaguchi Keiji Hirota, Hiroyuki Yoshitomi, Motomu Hashimoto, Shinji Maeda, Shin Teradaira, Naoshi Sugimoto, Tomoyuki Yamaguchi, Takashi Nomura, Hiromu Ito, Takashi Nakamura, Noriko Sakaguchi, Shimon Sakaguchi Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal model. The Journal of experimental medicine, 204, 12, 2803-12 The Journal of experimental medicine, 204, 12, 2803-12 The Journal of experimental medicine, 204, 12, 2803-12 2007/11/26 Refereed English Research paper(scientific journal) Disclose to all
Toshio Kitawaki, Norimitsu Kadowaki, Naoshi Sugimoto, Naotomo Kambe, Toshiyuki Hori, Yoshiki Miyachi, Tatsutoshi Nakahata, Takashi Uchiyama Toshio Kitawaki, Norimitsu Kadowaki, Naoshi Sugimoto, Naotomo Kambe, Toshiyuki Hori, Yoshiki Miyachi, Tatsutoshi Nakahata, Takashi Uchiyama Toshio Kitawaki, Norimitsu Kadowaki, Naoshi Sugimoto, Naotomo Kambe, Toshiyuki Hori, Yoshiki Miyachi, Tatsutoshi Nakahata, Takashi Uchiyama IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells. IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells. IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells. International immunology, 18, 12, 1789-99 International immunology, 18, 12, 1789-99 International immunology, 18, 12, 1789-99 2006/12 Refereed English Research paper(scientific journal) Disclose to all
Naoshi Sugimoto, Takatoku Oida, Keiji Hirota, Kyoko Nakamura, Takashi Nomura, Takashi Uchiyama, Shimon Sakaguchi Naoshi Sugimoto, Takatoku Oida, Keiji Hirota, Kyoko Nakamura, Takashi Nomura, Takashi Uchiyama, Shimon Sakaguchi Naoshi Sugimoto, Takatoku Oida, Keiji Hirota, Kyoko Nakamura, Takashi Nomura, Takashi Uchiyama, Shimon Sakaguchi Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. International immunology, 18, 8, 1197-209 International immunology, 18, 8, 1197-209 International immunology, 18, 8, 1197-209 2006/08 Refereed English Research paper(scientific journal) Disclose to all
K Kawamura, N Kadowaki, R Suzuki, S Udagawa, S Kasaoka, N Utoguchi, T Kitawaki, N Sugimoto, N Okada, K Maruyama, T Uchiyama K Kawamura, N Kadowaki, R Suzuki, S Udagawa, S Kasaoka, N Utoguchi, T Kitawaki, N Sugimoto, N Okada, K Maruyama, T Uchiyama K Kawamura, N Kadowaki, R Suzuki, S Udagawa, S Kasaoka, N Utoguchi, T Kitawaki, N Sugimoto, N Okada, K Maruyama, T Uchiyama Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity Dendritic cells that endocytosed antigen-containing IgG-liposomes elicit effective antitumor immunity JOURNAL OF IMMUNOTHERAPY, 29, 2, 165-174 JOURNAL OF IMMUNOTHERAPY, 29, 2, 165-174 JOURNAL OF IMMUNOTHERAPY, 29, 2, 165-174 2006/03 Refereed English Research paper(scientific journal) Disclose to all
Naoko Watanabe, Takayuki Takahashi, Naoshi Sugimoto, Yasuhiro Tanaka, Masayuki Kurata, Akiko Matsushita, Akinori Maeda, Kenichi Nagai, Kohji Nasu Naoko Watanabe, Takayuki Takahashi, Naoshi Sugimoto, Yasuhiro Tanaka, Masayuki Kurata, Akiko Matsushita, Akinori Maeda, Kenichi Nagai, Kohji Nasu Naoko Watanabe, Takayuki Takahashi, Naoshi Sugimoto, Yasuhiro Tanaka, Masayuki Kurata, Akiko Matsushita, Akinori Maeda, Kenichi Nagai, Kohji Nasu Excellent response of chemotherapy-resistant B-cell-type chronic lymphocytic leukemia with meningeal involvement to rituximab. Excellent response of chemotherapy-resistant B-cell-type chronic lymphocytic leukemia with meningeal involvement to rituximab. Excellent response of chemotherapy-resistant B-cell-type chronic lymphocytic leukemia with meningeal involvement to rituximab. International journal of clinical oncology, 10, 5, 357-61 International journal of clinical oncology, 10, 5, 357-61 International journal of clinical oncology, 10, 5, 357-61 2005/10 Refereed English Research paper(scientific journal) Disclose to all
Naoshi Sugimoto, Takayuki Ishikawa, Saori Gotoh, Isaku Shinzato, Akiko Matsushita, Kenichi Nagai, Noriko Ohgoh, Takayuki Takahashi Naoshi Sugimoto, Takayuki Ishikawa, Saori Gotoh, Isaku Shinzato, Akiko Matsushita, Kenichi Nagai, Noriko Ohgoh, Takayuki Takahashi Naoshi Sugimoto, Takayuki Ishikawa, Saori Gotoh, Isaku Shinzato, Akiko Matsushita, Kenichi Nagai, Noriko Ohgoh, Takayuki Takahashi Primary myelofibrosis terminated in basophilic leukemia and successful allogeneic bone marrow transplantation. Primary myelofibrosis terminated in basophilic leukemia and successful allogeneic bone marrow transplantation. Primary myelofibrosis terminated in basophilic leukemia and successful allogeneic bone marrow transplantation. International journal of hematology, 80, 2, 183-5 International journal of hematology, 80, 2, 183-5 International journal of hematology, 80, 2, 183-5 2004/08 Refereed English Research paper(scientific journal) Disclose to all
M Yanai, A Maeda, N Watanabe, N Sugimoto, A Matsushita, K Nagai, T Oida, T Takahashi M Yanai, A Maeda, N Watanabe, N Sugimoto, A Matsushita, K Nagai, T Oida, T Takahashi M Yanai, A Maeda, N Watanabe, N Sugimoto, A Matsushita, K Nagai, T Oida, T Takahashi Successful treatment of mu-heavy chain disease with fludarabine monophosphate: A case report Successful treatment of mu-heavy chain disease with fludarabine monophosphate: A case report Successful treatment of mu-heavy chain disease with fludarabine monophosphate: A case report INTERNATIONAL JOURNAL OF HEMATOLOGY, 79, 2, 174-177 INTERNATIONAL JOURNAL OF HEMATOLOGY, 79, 2, 174-177 INTERNATIONAL JOURNAL OF HEMATOLOGY, 79, 2, 174-177 2004/02 Refereed English Research paper(scientific journal) Disclose to all
N Watanabe, N Sugimoto, A Matsushita, A Maeda, K Nagai, K Hanioka, T Takahashi N Watanabe, N Sugimoto, A Matsushita, A Maeda, K Nagai, K Hanioka, T Takahashi N Watanabe, N Sugimoto, A Matsushita, A Maeda, K Nagai, K Hanioka, T Takahashi Association of intestinal malignant lymphoma and ulcerative colitis Association of intestinal malignant lymphoma and ulcerative colitis Association of intestinal malignant lymphoma and ulcerative colitis INTERNAL MEDICINE, 42, 12, 1183-1187 INTERNAL MEDICINE, 42, 12, 1183-1187 INTERNAL MEDICINE, 42, 12, 1183-1187 2003/12 Refereed English Research paper(scientific journal) Disclose to all
T Mochizuki, AA Karavanov, PE Curtiss, KT Ault, N Sugimoto, T Watabe, K Shiokawa, M Jamrich, KWY Cho, IB Dawid, M Taira T Mochizuki, AA Karavanov, PE Curtiss, KT Ault, N Sugimoto, T Watabe, K Shiokawa, M Jamrich, KWY Cho, IB Dawid, M Taira T Mochizuki, AA Karavanov, PE Curtiss, KT Ault, N Sugimoto, T Watabe, K Shiokawa, M Jamrich, KWY Cho, IB Dawid, M Taira Xlim-1 and LIM domain binding protein 1 cooperate with various transcription factors in the regulation of the goosecoid promoter Xlim-1 and LIM domain binding protein 1 cooperate with various transcription factors in the regulation of the goosecoid promoter Xlim-1 and LIM domain binding protein 1 cooperate with various transcription factors in the regulation of the goosecoid promoter DEVELOPMENTAL BIOLOGY, 224, 2, 470-485 DEVELOPMENTAL BIOLOGY, 224, 2, 470-485 DEVELOPMENTAL BIOLOGY, 224, 2, 470-485 2000/08 Refereed English Research paper(scientific journal) Disclose to all

  • <<
  • >>
Title language:
Misc
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
杉本直志, 中村壮, 江藤浩之, 江藤浩之 杉本直志, 中村壮, 江藤浩之, 江藤浩之 杉本直志, 中村壮, 江藤浩之, 江藤浩之 Hydrodynamic mechanism in platelet biogenesis: turbulence enables large-scale platelet production. 血液疾患と血球分化 血小板産生における流体力学機序:乱流による血小板大量産生 Hydrodynamic mechanism in platelet biogenesis: turbulence enables large-scale platelet production. 月刊血液内科, 82, 1 月刊血液内科, 82, 1 月刊血液内科, 82, 1 2021 Disclose to all
杉本直志, 江藤浩之, 江藤浩之 杉本直志, 江藤浩之, 江藤浩之 白血病・リンパ腫 iPS細胞を使った血液製剤の開発 白血病・リンパ腫 iPS細胞を使った血液製剤の開発 Medical Practice, 37, 9 Medical Practice, 37, 9 , 37, 9 2020 Disclose to all
杉本直志 杉本直志 iPS細胞を用いた血小板製剤の臨床応用の展望 iPS細胞を用いた血小板製剤の臨床応用の展望 血液事業, 43, 1 血液事業, 43, 1 , 43, 1 2020 Disclose to all
杉本直志, 江藤浩之, 江藤浩之 杉本直志, 江藤浩之, 江藤浩之 杉本直志, 江藤浩之, 江藤浩之 Development of large-scale production of highly functional platelets (Turbulence-driven production of iPSC-derived platelets) 細胞療法の新しい戦略 II.幹細胞ベース 12.高機能血小板の大量培養法の開発-乱流によるiPS細胞由来血小板の製造 Development of large-scale production of highly functional platelets (Turbulence-driven production of iPSC-derived platelets) 実験医学, 38, 17 実験医学, 38, 17 実験医学, 38, 17 2020 Disclose to all
石野 亮, 川瀬 有美, 北脇 年雄, 杉本 直志, 稲生 靖, 藤堂 具紀, 高折 晃史, 門脇 則光 石野 亮, 川瀬 有美, 北脇 年雄, 杉本 直志, 稲生 靖, 藤堂 具紀, 高折 晃史, 門脇 則光 石野 亮, 川瀬 有美, 北脇 年雄, 杉本 直志, 稲生 靖, 藤堂 具紀, 高折 晃史, 門脇 則光 がん治療用HSV-1を用いた造血器腫瘍に対するウイルス療法 がん治療用HSV-1を用いた造血器腫瘍に対するウイルス療法 がん治療用HSV-1を用いた造血器腫瘍に対するウイルス療法 日本がん免疫学会総会プログラム・抄録集, 23回, 86-86 日本がん免疫学会総会プログラム・抄録集, 23回, 86-86 日本がん免疫学会総会プログラム・抄録集, 23回, 86-86 2019/07 Japanese Disclose to all
杉本直志 杉本直志 iPS細胞を用いた血小板製剤の臨床応用の展望 iPS細胞を用いた血小板製剤の臨床応用の展望 血液事業, 42, 2 血液事業, 42, 2 , 42, 2 2019 Disclose to all
杉本直志, 江藤浩之, 江藤浩之 杉本直志, 江藤浩之, 江藤浩之 iPS cell-derived platelets 細胞治療の新時代 iPS細胞由来血小板 iPS cell-derived platelets 日本内科学会雑誌, 108, 7, 1397-1403 日本内科学会雑誌, 108, 7, 1397-1403 , 108, 7, 1397-1403 2019 Japanese Disclose to all
内田 俊平, 久保 博之, 横倉 繁行, 植村 麻希子, 杉本 直志, 今滝 修, 門脇 則光 内田俊平, 久保博之, 横倉繁行, 植村麻希子, 杉本直志, 今滝修, 門脇則光 内田 俊平, 久保 博之, 横倉 繁行, 植村 麻希子, 杉本 直志, 今滝 修, 門脇 則光 右心不全を契機に診断された心臓原発悪性リンパ腫の1例 右心不全を契機に診断された心臓原発悪性リンパ腫の1例 右心不全を契機に診断された心臓原発悪性リンパ腫の1例 臨床血液, 60, 5, 513-513 臨床血液, 60, 5, 513-513 臨床血液, 60, 5, 513-513 2019 Japanese Disclose to all
杉本 直志, 江藤浩之 杉本 直志, 江藤浩之 iPS細胞からの血小板産生 iPS細胞からの血小板産生 臨床血液, 59, 10, 45-53 臨床血液, 59, 10, 45-53 , 59, 10, 45-53 2018/10 Japanese Article, review, commentary, editorial, etc.(scientific journal) Disclose to all
山本 和代, 北脇 年雄, 杉本 直志, 川瀬 有美, 末木 佑季, 藤田 晴之, 高折 晃史, 門脇 則光 山本 和代, 北脇 年雄, 杉本 直志, 川瀬 有美, 末木 佑季, 藤田 晴之, 高折 晃史, 門脇 則光 山本 和代, 北脇 年雄, 杉本 直志, 川瀬 有美, 末木 佑季, 藤田 晴之, 高折 晃史, 門脇 則光 レナリドミドは骨髄系樹状細胞に作用して抗骨髄腫および抗炎症効果を発揮する(Lenalidomide performs anti-myeloma and anti-inflammatory function through acting on myeloid DCs) レナリドミドは骨髄系樹状細胞に作用して抗骨髄腫および抗炎症効果を発揮する(Lenalidomide performs anti-myeloma and anti-inflammatory function through acting on myeloid DCs) レナリドミドは骨髄系樹状細胞に作用して抗骨髄腫および抗炎症効果を発揮する(Lenalidomide performs anti-myeloma and anti-inflammatory function through acting on myeloid DCs) 臨床血液, 59, 9, 1541-1541 臨床血液, 59, 9, 1541-1541 臨床血液, 59, 9, 1541-1541 2018/09 English Disclose to all
石野 亮, 川瀬 有美, 北脇 年雄, 杉本 直志, 稲生 靖, 藤堂 具紀, 高折 晃史, 門脇 則光 石野 亮, 川瀬 有美, 北脇 年雄, 杉本 直志, 稲生 靖, 藤堂 具紀, 高折 晃史, 門脇 則光 石野 亮, 川瀬 有美, 北脇 年雄, 杉本 直志, 稲生 靖, 藤堂 具紀, 高折 晃史, 門脇 則光 造血器腫瘍に対するHSV-1ウイルス療法の効果規定因子(A determining factor in efficacy of oncolytic virus therapy with HSV-1 for hematologic malignancies) 造血器腫瘍に対するHSV-1ウイルス療法の効果規定因子(A determining factor in efficacy of oncolytic virus therapy with HSV-1 for hematologic malignancies) 造血器腫瘍に対するHSV-1ウイルス療法の効果規定因子(A determining factor in efficacy of oncolytic virus therapy with HSV-1 for hematologic malignancies) 臨床血液, 59, 9, 1517-1517 臨床血液, 59, 9, 1517-1517 臨床血液, 59, 9, 1517-1517 2018/09 English Disclose to all
石野 亮, 川瀬 有美, 北脇 年雄, 杉本 直志, 稲生 靖, 藤堂 具紀, 高折 晃史, 門脇 則光 石野 亮, 川瀬 有美, 北脇 年雄, 杉本 直志, 稲生 靖, 藤堂 具紀, 高折 晃史, 門脇 則光 石野 亮, 川瀬 有美, 北脇 年雄, 杉本 直志, 稲生 靖, 藤堂 具紀, 高折 晃史, 門脇 則光 造血器腫瘍に対するHSV-1ウイルス療法の効果規定因子 造血器腫瘍に対するHSV-1ウイルス療法の効果規定因子 造血器腫瘍に対するHSV-1ウイルス療法の効果規定因子 日本がん免疫学会総会プログラム・抄録集, 22回, 78-78 日本がん免疫学会総会プログラム・抄録集, 22回, 78-78 日本がん免疫学会総会プログラム・抄録集, 22回, 78-78 2018/07 Japanese Disclose to all
杉本直志, 杉本直志, 江藤浩之, 江藤浩之 杉本直志, 杉本直志, 江藤浩之, 江藤浩之 Development of iPSC-derived blood products iPS細胞を用いた血液製剤の開発 Development of iPSC-derived blood products 月刊血液内科, 76, 4, 555-561 月刊血液内科, 76, 4, 555-561 , 76, 4, 555-561 2018 Japanese Article, review, commentary, editorial, etc.(trade magazine, newspaper, online media) Disclose to all
杉本直志, 杉本直志, 門脇則光 杉本直志, 杉本直志, 門脇則光 造血器腫瘍と免疫・凝固系 第2回 造血器腫瘍と免疫療法 造血器腫瘍と免疫・凝固系 第2回 造血器腫瘍と免疫療法 Thrombosis Medicine, 8, 1, 71-74 Thrombosis Medicine, 8, 1, 71-74 , 8, 1, 71-74 2018 Japanese Article, review, commentary, editorial, etc.(trade magazine, newspaper, online media) Disclose to all
杉本直志, 杉本直志, 江藤浩之, 江藤浩之 杉本直志, 杉本直志, 江藤浩之, 江藤浩之 iPS細胞からの血小板製剤の作製 iPS細胞からの血小板製剤の作製 日本輸血細胞治療学会誌, 64, 2 日本輸血細胞治療学会誌, 64, 2 , 64, 2 2018 Disclose to all
渕崎晶弘, 森純平, 越智洋輔, 林智也, 田中光信, 寺田周弘, 寺田あかね, 木村貴文, 谷慶彦, 下垣一成, 高橋順子, 杉本直志, 杉本直志, 中村壮, 清水伸, 江藤浩之, 江藤浩之 渕崎晶弘, 森純平, 越智洋輔, 林智也, 田中光信, 寺田周弘, 寺田あかね, 木村貴文, 谷慶彦, 下垣一成, 高橋順子, 杉本直志, 杉本直志, 中村壮, 清水伸, 江藤浩之, 江藤浩之 iPS細胞由来血小板の品質評価(献血由来血小板との違い) iPS細胞由来血小板の品質評価(献血由来血小板との違い) 日本輸血細胞治療学会誌, 64, 2 日本輸血細胞治療学会誌, 64, 2 , 64, 2 2018 Disclose to all
N. Sugimoto, K. Eto N. Sugimoto, K. Eto N. Sugimoto, K. Eto Platelet production from induced pluripotent stem cells Platelet production from induced pluripotent stem cells Platelet production from induced pluripotent stem cells JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 15, 9, 1717-1727 JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 15, 9, 1717-1727 JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 15, 9, 1717-1727 2017/09 Refereed English Article, review, commentary, editorial, etc.(scientific journal) Disclose to all
江藤浩之, 江藤浩之, 中村壮, 清水伸, 杉本直志, 広瀬秀徳, 重盛智大, 伊東幸敬, 西河芳樹, 下垣一成, 下垣一成, 高橋順子, 高橋順子, 木村貴文, 木村貴文, 谷慶彦, 谷慶彦, 寺田周弘, 渡邊直英, 半田誠, 野川誠之 江藤浩之, 江藤浩之, 中村壮, 清水伸, 杉本直志, 広瀬秀徳, 重盛智大, 伊東幸敬, 西河芳樹, 下垣一成, 下垣一成, 高橋順子, 高橋順子, 木村貴文, 木村貴文, 谷慶彦, 谷慶彦, 寺田周弘, 渡邊直英, 半田誠, 野川誠之 iPS血小板は,献血PC製剤とは別物か? iPS血小板は,献血PC製剤とは別物か? 日本輸血細胞治療学会誌, 63, 3 日本輸血細胞治療学会誌, 63, 3 , 63, 3 2017 Disclose to all
鈴木大助, 杉本直志, 吉川典秀, 中村壮, 遠藤大, 堀田秋津, 江藤浩之 鈴木大助, 杉本直志, 吉川典秀, 中村壮, 遠藤大, 堀田秋津, 江藤浩之 NK細胞から見たHLA欠失血小板の有用性と安全性の保証 NK細胞から見たHLA欠失血小板の有用性と安全性の保証 再生医療, 16 再生医療, 16 , 16 2017 Disclose to all
K. Ishiyama, T. Kitawaki, N. Sugimoto, T. Sozu, N. Anzai, M. Okada, M. Nohgawa, K. Hatanaka, N. Arima, T. Ishikawa, S. Tabata, T. Onaka, S. Oka, Y. Nakabo, R. Amakawa, M. Matsui, T. Moriguchi, A. Takaori-Kondo, N. Kadowaki K. Ishiyama, T. Kitawaki, N. Sugimoto, T. Sozu, N. Anzai, M. Okada, M. Nohgawa, K. Hatanaka, N. Arima, T. Ishikawa, S. Tabata, T. Onaka, S. Oka, Y. Nakabo, R. Amakawa, M. Matsui, T. Moriguchi, A. Takaori-Kondo, N. Kadowaki K. Ishiyama, T. Kitawaki, N. Sugimoto, T. Sozu, N. Anzai, M. Okada, M. Nohgawa, K. Hatanaka, N. Arima, T. Ishikawa, S. Tabata, T. Onaka, S. Oka, Y. Nakabo, R. Amakawa, M. Matsui, T. Moriguchi, A. Takaori-Kondo, N. Kadowaki Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib (vol 31, 203, 2017) Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib (vol 31, 203, 2017) Principal component analysis uncovers cytomegalovirus-associated NK cell activation in Ph+ leukemia patients treated with dasatinib (vol 31, 203, 2017) LEUKEMIA, 31, 1, 268-268 LEUKEMIA, 31, 1, 268-268 LEUKEMIA, 31, 1, 268-268 2017/01 English Other Disclose to all
鈴木大助, 杉本直志, 江藤浩之 鈴木大助, 杉本直志, 江藤浩之 Current approach of platelet transfusion for regenerative medicine 血小板再生と臨床応用への道のり Current approach of platelet transfusion for regenerative medicine 月刊腎臓内科・泌尿器科, 5, 6, 574-580 月刊腎臓内科・泌尿器科, 5, 6, 574-580 , 5, 6, 574-580 2017 Japanese Disclose to all
石野 亮, 川瀬 有美, 北脇 年雄, 杉本 直志, 稲生 靖, 藤堂 具紀, 高折 晃史, 門脇 則光 石野亮, 石野亮, 川瀬有美, 北脇年雄, 杉本直志, 稲生靖, 藤堂具紀, 高折晃史, 門脇則光 石野 亮, 川瀬 有美, 北脇 年雄, 杉本 直志, 稲生 靖, 藤堂 具紀, 高折 晃史, 門脇 則光 造血器腫瘍に対するHSV-1ウイルス療法の開発 造血器腫瘍に対するHSV-1ウイルス療法の開発 造血器腫瘍に対するHSV-1ウイルス療法の開発 日本がん免疫学会総会プログラム・抄録集, 21st, 128-128 日本がん免疫学会総会プログラム・抄録集, 21st, 128-128 日本がん免疫学会総会プログラム・抄録集, 21st, 128-128 2017 Japanese Disclose to all
杉本直志, 江藤浩之 杉本直志, 江藤浩之 杉本直志, 江藤浩之 Development of iPS cell-derived blood products and production guidelines iPS細胞を用いた血液製剤の開発と法整備 Development of iPS cell-derived blood products and production guidelines 臨床血液, 58, 10, 2150-2159 臨床血液, 58, 10, 2150-2159 臨床血液, 58, 10, 2150-2159 2017 Japanese Article, review, commentary, editorial, etc.(scientific journal) Disclose to all
Sugimoto Naoshi, Eto Koji 杉本直志, 江藤浩之 Sugimoto Naoshi, Eto Koji Innovation of Transfusion Medicine with iPS Cells iPS細胞を用いた新たな輸血医療 Innovation of Transfusion Medicine with iPS Cells Nihon Naika Gakkai Zasshi, 106, 4, 843-849 日本内科学会雑誌, 106, 4, 843-849 Nihon Naika Gakkai Zasshi, 106, 4, 843-849 2017 Japanese Article, review, commentary, editorial, etc.(scientific journal) Disclose to all
Kazuya Hashimoto, Satoshi Matsuura, Yoshihiko Fujita, Karin Hayashi, Naoshi Sugimoto, Takuya Yamamoto, Hirohide Saito, Koji Eto Kazuya Hashimoto, Satoshi Matsuura, Yoshihiko Fujita, Karin Hayashi, Naoshi Sugimoto, Takuya Yamamoto, Hirohide Saito, Koji Eto Kazuya Hashimoto, Satoshi Matsuura, Yoshihiko Fujita, Karin Hayashi, Naoshi Sugimoto, Takuya Yamamoto, Hirohide Saito, Koji Eto Synthetic miRNA Switch Technology Elucidates Heterogeneity in Regulation of Immortalized Megakaryocyte Cell Lines, Associated with Improvement of Platelet Generation Efficiency for Clinical Use Synthetic miRNA Switch Technology Elucidates Heterogeneity in Regulation of Immortalized Megakaryocyte Cell Lines, Associated with Improvement of Platelet Generation Efficiency for Clinical Use Synthetic miRNA Switch Technology Elucidates Heterogeneity in Regulation of Immortalized Megakaryocyte Cell Lines, Associated with Improvement of Platelet Generation Efficiency for Clinical Use BLOOD, 128, 22 BLOOD, 128, 22 BLOOD, 128, 22 2016/12 English Research paper, summary (international conference) Disclose to all
Daisuke Suzuki, Naoshi Sugimoto, Norihide Yoshikawa, Hiroshi Endo, Sou Nakamura, Akitsu Hotta, Koji Eto Daisuke Suzuki, Naoshi Sugimoto, Norihide Yoshikawa, Hiroshi Endo, Sou Nakamura, Akitsu Hotta, Koji Eto Daisuke Suzuki, Naoshi Sugimoto, Norihide Yoshikawa, Hiroshi Endo, Sou Nakamura, Akitsu Hotta, Koji Eto Natural Killer Cell Activities Against iPSCs-Derived HLA-Knockout Platelets and Megakaryocytes Reveal Perfect Rejection Profiles for Allotransfusion Natural Killer Cell Activities Against iPSCs-Derived HLA-Knockout Platelets and Megakaryocytes Reveal Perfect Rejection Profiles for Allotransfusion Natural Killer Cell Activities Against iPSCs-Derived HLA-Knockout Platelets and Megakaryocytes Reveal Perfect Rejection Profiles for Allotransfusion BLOOD, 128, 22 BLOOD, 128, 22 BLOOD, 128, 22 2016/12 English Research paper, summary (international conference) Disclose to all
Yukitaka Ito, Sou Nakamura, Tomohiro Shigemori, Naoshi Sugimoto, Yoshikazu Kato, Kazuya Hashimoto, Naohide Watanabe, Masayuki Nogawa, Makoto Handa, Satoshi Nishimura, Koji Eto Yukitaka Ito, Sou Nakamura, Tomohiro Shigemori, Naoshi Sugimoto, Yoshikazu Kato, Kazuya Hashimoto, Naohide Watanabe, Masayuki Nogawa, Makoto Handa, Satoshi Nishimura, Koji Eto Yukitaka Ito, Sou Nakamura, Tomohiro Shigemori, Naoshi Sugimoto, Yoshikazu Kato, Kazuya Hashimoto, Naohide Watanabe, Masayuki Nogawa, Makoto Handa, Satoshi Nishimura, Koji Eto High-Vorticity with Periodic Flow Enhances in Vitro Biogenesis of Healthy Platelets from iPSC-Derived-Megakaryocytes High-Vorticity with Periodic Flow Enhances in Vitro Biogenesis of Healthy Platelets from iPSC-Derived-Megakaryocytes High-Vorticity with Periodic Flow Enhances in Vitro Biogenesis of Healthy Platelets from iPSC-Derived-Megakaryocytes BLOOD, 128, 22 BLOOD, 128, 22 BLOOD, 128, 22 2016/12 English Research paper, summary (international conference) Disclose to all
Ken-ichi Ishiyama, Toshio Kitawaki, Naoshi Sugimoto, Akifumi Takaori-Kondo, Norimitsu Kadowaki Ken-ichi Ishiyama, Toshio Kitawaki, Naoshi Sugimoto, Akifumi Takaori-Kondo, Norimitsu Kadowaki Ken-ichi Ishiyama, Toshio Kitawaki, Naoshi Sugimoto, Akifumi Takaori-Kondo, Norimitsu Kadowaki Expansion of Dysfunctional CD56-Negative NK Cells Is a Hallmark of NK Cell Activation in Ph+ Leukemia Patients Treated with Dasatinib Expansion of Dysfunctional CD56-Negative NK Cells Is a Hallmark of NK Cell Activation in Ph+ Leukemia Patients Treated with Dasatinib Expansion of Dysfunctional CD56-Negative NK Cells Is a Hallmark of NK Cell Activation in Ph+ Leukemia Patients Treated with Dasatinib BLOOD, 128, 22 BLOOD, 128, 22 BLOOD, 128, 22 2016/12 English Research paper, summary (international conference) Disclose to all
石野 亮, 川瀬 有美, 北脇 年雄, 杉本 直志, 稲生 靖, 藤堂 具紀, 高折 晃史, 門脇 則光 石野 亮, 川瀬 有美, 北脇 年雄, 杉本 直志, 稲生 靖, 藤堂 具紀, 高折 晃史, 門脇 則光 石野 亮, 川瀬 有美, 北脇 年雄, 杉本 直志, 稲生 靖, 藤堂 具紀, 高折 晃史, 門脇 則光 造血器腫瘍に対するHSV-1ウイルス療法の開発 造血器腫瘍に対するHSV-1ウイルス療法の開発 造血器腫瘍に対するHSV-1ウイルス療法の開発 日本がん免疫学会総会プログラム・抄録集, 20回, 136-136 日本がん免疫学会総会プログラム・抄録集, 20回, 136-136 日本がん免疫学会総会プログラム・抄録集, 20回, 136-136 2016/06 Japanese Disclose to all
杉本直志, 江藤浩之 杉本直志, 江藤浩之 iPS細胞技術による血小板製剤の開発と臨床試験 iPS細胞技術による血小板製剤の開発と臨床試験 日本臨床, 74 日本臨床, 74 , 74 2016 Disclose to all
鈴木大助, 杉本直志, 吉川典秀, 中村壮, 遠藤大, 堀田秋津, 江藤浩之 鈴木大助, 杉本直志, 吉川典秀, 中村壮, 遠藤大, 堀田秋津, 江藤浩之 iPS細胞技術に基づくHLA欠失血小板の作製と実用可能性の検証 iPS細胞技術に基づくHLA欠失血小板の作製と実用可能性の検証 再生医療, 15 再生医療, 15 , 15 2016 Disclose to all
Naoshi Sugimoto, Yong-Jun Liu Naoshi Sugimoto, Yong-Jun Liu Naoshi Sugimoto, Yong-Jun Liu DUSP4 Stabilizes FOXP3 Expression In Human Regulatory T Cells DUSP4 Stabilizes FOXP3 Expression In Human Regulatory T Cells DUSP4 Stabilizes FOXP3 Expression In Human Regulatory T Cells BLOOD, 122, 21 BLOOD, 122, 21 BLOOD, 122, 21 2013/11 English Research paper, summary (international conference) Disclose to all
S. Sakaguchi, N. Sugimoto, M. Ono, T. Oida, K. Hirota, T. Yamaguchi, T. Nomura S. Sakaguchi, N. Sugimoto, M. Ono, T. Oida, K. Hirota, T. Yamaguchi, T. Nomura S. Sakaguchi, N. Sugimoto, M. Ono, T. Oida, K. Hirota, T. Yamaguchi, T. Nomura Foxp3-expressing regulatory T cells in self-tolerance and autoimmune disease Foxp3-expressing regulatory T cells in self-tolerance and autoimmune disease Foxp3-expressing regulatory T cells in self-tolerance and autoimmune disease JOURNAL OF NEUROIMMUNOLOGY, 178, 31-32 JOURNAL OF NEUROIMMUNOLOGY, 178, 31-32 JOURNAL OF NEUROIMMUNOLOGY, 178, 31-32 2006/09 English Research paper, summary (international conference) Disclose to all
松永恭子, 矢野美由紀, 浄慶幸江, 増田由佳子, 迫田裕之, 炬口真理子, 河野誠司, 熊谷俊一, 西郷勝康, 杉本直志, 永井謙一, 高橋隆幸, 矢部博樹, 近藤信一, 稲葉亨, 岡本茂高, 古田香穂, シアンプルナワチ メイラニ, 巽英二 松永恭子, 矢野美由紀, 浄慶幸江, 増田由佳子, 迫田裕之, 炬口真理子, 河野誠司, 熊谷俊一, 西郷勝康, 杉本直志, 永井謙一, 高橋隆幸, 矢部博樹, 近藤信一, 稲葉亨, 岡本茂高, 古田香穂, シアンプルナワチ メイラニ, 巽英二 顆粒発達の強い細胞を含むDR陰性AML(M2):2例におけるFlt3ITD検出と3例の塗抹標本形態 顆粒発達の強い細胞を含むDR陰性AML(M2):2例におけるFlt3ITD検出と3例の塗抹標本形態 日本検査血液学会雑誌, 7, 2 日本検査血液学会雑誌, 7, 2 , 7, 2 2006 Disclose to all
北脇 年雄, 門脇 則光, 杉本 直志, 神戸 直智, 宮地 良樹, 内山 卓 北脇 年雄, 門脇 則光, 杉本 直志, 神戸 直智, 宮地 良樹, 内山 卓 北脇 年雄, 門脇 則光, 杉本 直志, 神戸 直智, 宮地 良樹, 内山 卓 活性化ヒト肥満細胞による単球由来樹状細胞の成熟とTh2反応の誘導 活性化ヒト肥満細胞による単球由来樹状細胞の成熟とTh2反応の誘導 活性化ヒト肥満細胞による単球由来樹状細胞の成熟とTh2反応の誘導 日本血液学会・日本臨床血液学会総会プログラム・抄録集, 67回・47回, 821-821 日本血液学会・日本臨床血液学会総会プログラム・抄録集, 67回・47回, 821-821 日本血液学会・日本臨床血液学会総会プログラム・抄録集, 67回・47回, 821-821 2005/09 Japanese Disclose to all
北脇 年雄, 門脇 則光, 杉本 直志, 神戸 直智, 宮地 良樹, 内山 卓 北脇 年雄, 門脇 則光, 杉本 直志, 神戸 直智, 宮地 良樹, 内山 卓 北脇 年雄, 門脇 則光, 杉本 直志, 神戸 直智, 宮地 良樹, 内山 卓 活性化ヒト肥満細胞による単球由来樹状細胞の成熟とTh2反応の誘導 活性化ヒト肥満細胞による単球由来樹状細胞の成熟とTh2反応の誘導 活性化ヒト肥満細胞による単球由来樹状細胞の成熟とTh2反応の誘導 日本リンパ網内系学会会誌, 45, 117-117 日本リンパ網内系学会会誌, 45, 117-117 日本リンパ網内系学会会誌, 45, 117-117 2005/06 Japanese Disclose to all
北脇 年雄, 杉本 直志, 門脇 則光, 神戸 直智, 内山 卓 北脇 年雄, 杉本 直志, 門脇 則光, 神戸 直智, 内山 卓 北脇 年雄, 杉本 直志, 門脇 則光, 神戸 直智, 内山 卓 ヒト肥満細胞による樹状細胞の活性化とT細胞反応への影響 ヒト肥満細胞による樹状細胞の活性化とT細胞反応への影響 ヒト肥満細胞による樹状細胞の活性化とT細胞反応への影響 日本免疫学会総会・学術集会記録, 34, 200-200 日本免疫学会総会・学術集会記録, 34, 200-200 日本免疫学会総会・学術集会記録, 34, 200-200 2004/11 Japanese Disclose to all
一戸辰夫, 杉本直志, 内山卓 一戸辰夫, 杉本直志, 内山卓 複数以上のHLA座不一致の造血幹細胞移植 複数以上のHLA座不一致の造血幹細胞移植 臨床病理レビュー特集, 122 臨床病理レビュー特集, 122 , 122 2002 Disclose to all
西馬信一, 杉本直志, 高橋健, 木本直哉, 上嶋一臣, 岡田明彦, 岡部純弘, 樫田博史, 小西豊 西馬信一, 杉本直志, 高橋健, 木本直哉, 上嶋一臣, 岡田明彦, 岡部純弘, 樫田博史, 小西豊 血球どん食症候群を合併した重症急性すい炎の1例 血球どん食症候群を合併した重症急性すい炎の1例 日本消化器病学会雑誌, 98 日本消化器病学会雑誌, 98 , 98 2001 Disclose to all
永井謙一, 杉本直志, 松下章子, 前田明則, 高橋隆幸, 浜野照明 永井謙一, 杉本直志, 松下章子, 前田明則, 高橋隆幸, 浜野照明 IgA-λ型M蛋白血症と胸腺腫りゅうを伴ったlymphoplasmacytoid lymphomaの一例 IgA-λ型M蛋白血症と胸腺腫りゅうを伴ったlymphoplasmacytoid lymphomaの一例 臨床血液, 42, 10 臨床血液, 42, 10 , 42, 10 2001 Disclose to all
杉本直志, 松下章子, 前田明則, 永井謙一, 高橋隆幸 杉本直志, 松下章子, 前田明則, 永井謙一, 高橋隆幸 t(3;21)(q26;q22)転座を有した2次性急性骨髄性白血病の一例 t(3;21)(q26;q22)転座を有した2次性急性骨髄性白血病の一例 International Journal of Hematology. Supplement, 73, Supplement 1 International Journal of Hematology. Supplement, 73, Supplement 1 , 73, Supplement 1 2001 Disclose to all
大郷典子, 菅野優子, 藤井公男, 杉本直志 大郷典子, 菅野優子, 藤井公男, 杉本直志 よう虫病の1例 よう虫病の1例 皮膚, 42, 4 皮膚, 42, 4 , 42, 4 2000 Disclose to all
杉本直志, 松下章子, 前田明則, 永井謙一, 高橋隆幸, 巽英二 杉本直志, 松下章子, 前田明則, 永井謙一, 高橋隆幸, 巽英二 AML-M3様の形態を示した,AML-M2の一例 AML-M3様の形態を示した,AML-M2の一例 臨床血液, 41, 10 臨床血液, 41, 10 , 41, 10 2000 Disclose to all
松下章子, 杉本直志, 前田明則, 永井謙一, 高橋隆幸 松下章子, 杉本直志, 前田明則, 永井謙一, 高橋隆幸 再発の度にlow dose Ara-Cが有効で,7回の完全寛解が得られたAML-M2の一症例 再発の度にlow dose Ara-Cが有効で,7回の完全寛解が得られたAML-M2の一症例 臨床血液, 41, 10 臨床血液, 41, 10 , 41, 10 2000 Disclose to all
永井謙一, 中山志郎, 杉本直志, 松下章子, 前田明則, 高橋隆幸 永井謙一, 中山志郎, 杉本直志, 松下章子, 前田明則, 高橋隆幸 cryoglobulinの性格を有するIgG-κ型骨髄腫の一例 cryoglobulinの性格を有するIgG-κ型骨髄腫の一例 臨床血液, 41, 10 臨床血液, 41, 10 , 41, 10 2000 Disclose to all

  • <<
  • >>
Title language:
Conference Activities & Talks
Title Title(Japanese) Title(English) Conference Conference(Japanese) Conference(English) Promotor Promotor(Japanese) Promotor(English) Date Language Assortment Disclose
iPS細胞技術を用いた造血システムの再構成と治療への応用[Invited] iPS細胞技術を用いた造血システムの再構成と治療への応用 [Invited] 第81回日本血液学会学術集会 第81回日本血液学会学術集会 2019/10/11 Japanese Oral presentation(invited, special) Disclose to all
iPS細胞を用いた血小板製剤の臨床応用の展望[Invited] iPS細胞を用いた血小板製剤の臨床応用の展望 [Invited] 第43回日本血液事業学会 第43回日本血液事業学会 2019/10/02 Japanese Oral presentation(invited, special) Disclose to all
Turbulence enables large scale production and clinical application of iPS cell-derived platelets[Invited] 乱流が実現したiPS血小板の大量製造と臨床応用 [Invited] Turbulence enables large scale production and clinical application of iPS cell-derived platelets [Invited] 第17回先端血液学セミナー 第17回先端血液学セミナー 2019/06/08 Japanese Oral presentation(invited, special) Disclose to all
iPS血小板の開発と臨床応用[Invited] iPS血小板の開発と臨床応用 [Invited] 第18回先端医療フォーラム 第18回先端医療フォーラム 2019/05/31 Japanese Oral presentation(invited, special) Disclose to all
iPS細胞由来血小板製剤の開発と将来[Invited] iPS細胞由来血小板製剤の開発と将来 [Invited] 第50回日赤薬剤師会血液センター研究会 第50回日赤薬剤師会血液センター研究会 2019/03/10 Japanese Oral presentation(invited, special) Disclose to all
Environmental Cell-Matrix Adhesion Modulates Pluripotent Stem Cell Fate toward Definitive Hemogenic Endothelium and Hematopoietic Progenitor Cells Environmental Cell-Matrix Adhesion Modulates Pluripotent Stem Cell Fate toward Definitive Hemogenic Endothelium and Hematopoietic Progenitor Cells Environmental Cell-Matrix Adhesion Modulates Pluripotent Stem Cell Fate toward Definitive Hemogenic Endothelium and Hematopoietic Progenitor Cells 60th American Society of Hematology Annual Meeting and Exposition 第60回 米国血液学会年次集会 60th American Society of Hematology Annual Meeting and Exposition 2018/12/01 English Poster presentation Disclose to all
iPS血小板の臨床応用に向けて[Invited] iPS血小板の臨床応用に向けて [Invited] 第110回近畿血液学地方会 第110回近畿血液学地方会 2018/11/10 Japanese Oral presentation(invited, special) Disclose to all
HLA クラスI欠失ヒトiPS細胞由来血小板の抗HLA抗体およびNK細胞に対する免疫逃避 HLA クラスI欠失ヒトiPS細胞由来血小板の抗HLA抗体およびNK細胞に対する免疫逃避 第80回日本血液学会学術集会 第80回日本血液学会学術集会 2018/10/14 Japanese Poster presentation Disclose to all
iPS細胞からの血小板産生[Invited] iPS細胞からの血小板産生 [Invited] 第80回日本血液学会学術集会 第80回日本血液学会学術集会 2018/10/14 Japanese Oral presentation(invited, special) Disclose to all
新規の物理化学調節機構が1011個の血小板製造を可能にする 新規の物理化学調節機構が1011個の血小板製造を可能にする 第80回日本血液学会学術集会 第80回日本血液学会学術集会 2018/10/13 Japanese Oral presentation(general) Disclose to all
レナリドミドは骨髄系樹状細胞に作用して抗骨髄腫および抗炎症作用を発揮する レナリドミドは骨髄系樹状細胞に作用して抗骨髄腫および抗炎症作用を発揮する 2018/10/12 Japanese Oral presentation(general) Disclose to all
造血器腫瘍に対するHSV-1ウイルス療法の効果規定因子 造血器腫瘍に対するHSV-1ウイルス療法の効果規定因子 2018/10/12 Japanese Oral presentation(general) Disclose to all
A novel β1-tubulin-based megakaryocyte reporter system identifies compounds that promote megakaryocyte maturation and platelet production A novel β1-tubulin-based megakaryocyte reporter system identifies compounds that promote megakaryocyte maturation and platelet production A novel β1-tubulin-based megakaryocyte reporter system identifies compounds that promote megakaryocyte maturation and platelet production 23rd Congress of European Hematology Association Meeting 23rd Congress of European Hematology Association Meeting 23rd Congress of European Hematology Association Meeting 2018/06/14 English Oral presentation(general) Disclose to all
iPS細胞からの血小板の作製[Invited] iPS細胞からの血小板の作製 [Invited] 第66回日本輸血・細胞治療学会総会 第66回日本輸血・細胞治療学会総会 2018/05/25 Japanese Symposium workshop panel(nominated) Disclose to all
HLA gene knockout in human iPS cells: a tool in developing versatile cellular regenerative therapy[Invited] HLA gene knockout in human iPS cells: a tool in developing versatile cellular regenerative therapy [Invited] HLA gene knockout in human iPS cells: a tool in developing versatile cellular regenerative therapy [Invited] 第26回日本組織適合性学会大会 第26回日本組織適合性学会大会 2017/10/28 English Public discourse, seminar, tutorial, course, lecture and others Disclose to all
iPS細胞を用いた血液製剤の開発と法整備[Invited] iPS細胞を用いた血液製剤の開発と法整備 [Invited] 第79回日本血液学会学術集会 第79回日本血液学会学術集会 2017/10/21 Japanese Public discourse, seminar, tutorial, course, lecture and others Disclose to all
Allogenic hematopoietic stem cell transplantations of the elderly at Kyoto University Hospital 京都大学医学部附属病院における高齢者の同種造血幹細胞移植の成績 Allogenic hematopoietic stem cell transplantations of the elderly at Kyoto University Hospital 第77回日本血液学会学術集会 第77回日本血液学会学術集会 2015/10 Japanese Oral presentation(general) Disclose to all
Helicase Proteins DHX29 and RIG-I Cosense Cytosolic Nucleic Acids in the Human Airway System Helicase Proteins DHX29 and RIG-I Cosense Cytosolic Nucleic Acids in the Human Airway System Helicase Proteins DHX29 and RIG-I Cosense Cytosolic Nucleic Acids in the Human Airway System 口演(Best Presentation Award)、第43回日本免疫学会学術集会(2014), Kyoto 口演(Best Presentation Award)、第43回日本免疫学会学術集会(2014), Kyoto 2014/12 English Oral presentation(general) Disclose to all
ヘリカーゼ・タンパクDHX29とRIG-Iによるヒト気道組織のウィルス/核酸の細胞質内センシングとサイトカイン産生[Invited] ヘリカーゼ・タンパクDHX29とRIG-Iによるヒト気道組織のウィルス/核酸の細胞質内センシングとサイトカイン産生 [Invited] 招待講演、第10回感染症サイトカイン研究会 (2014)、 神戸 招待講演、第10回感染症サイトカイン研究会 (2014)、 神戸 2014 Japanese Public discourse, seminar, tutorial, course, lecture and others Disclose to all
DUSP4 Stabilizes FOXP3 Expression In Human Regulatory T Cells DUSP4 Stabilizes FOXP3 Expression In Human Regulatory T Cells DUSP4 Stabilizes FOXP3 Expression In Human Regulatory T Cells 55th Annual Meeting of the American Society of Hematology (2013), New Orleans 55th Annual Meeting of the American Society of Hematology (2013), New Orleans 55th Annual Meeting of the American Society of Hematology (2013), New Orleans 2013/12 English Poster presentation Disclose to all
TGFβによるナイーブCD4+T細胞のFoxp3遺伝子発現誘導の定量的解析 TGFβによるナイーブCD4+T細胞のFoxp3遺伝子発現誘導の定量的解析 第34回日本免疫学会総会 (2004) 第34回日本免疫学会総会 (2004) 2004 Oral presentation(general) Disclose to all
高度の好塩基球増多を呈し同種骨髄移植にて軽快した原発性骨髄線維症の一例 高度の好塩基球増多を呈し同種骨髄移植にて軽快した原発性骨髄線維症の一例 第60回日本血液学会学術集会 第60回日本血液学会学術集会 1998/03 Japanese Poster presentation Disclose to all
Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis 第36回日本免疫学会学術集会 (2006), Osaka 第36回日本免疫学会学術集会 (2006), Osaka English Oral presentation(general) Disclose to all
細胞質核酸センサーによる感染防御とその臨床的意義 細胞質核酸センサーによる感染防御とその臨床的意義 招待講演、第3回京都血液フォーラム (2015) 招待講演、第3回京都血液フォーラム (2015) Japanese Public discourse, seminar, tutorial, course, lecture and others Disclose to all

  • <<
  • >>
Title language:
Books etc
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Publisher Publisher(Japanese) Publisher(English) Publication date Language Type Disclose
杉本 直志 杉本 直志 ハリソン内科学 ハリソン内科学 2017 Joint Translation Disclose to all
Title language:
External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)
Type Position Title(Japanese) Title(English) Period
基盤研究(C) Representative 血液細胞の免疫反応および造血器腫瘍における核酸センサー分子DHX29の役割 (平成29年度分) 2017/04/01-2018/03/31